TRAM Snapshot of App at Pub for Oppostn

RADICAVA ORS

Mitsubishi Tanabe Pharma Corporation

TRAM Snapshot of App at Pub for Oppostn

Trademark Snap Shot Publication Stylesheet
(Table presents the data on Publication Approval)

OVERVIEW

SERIAL NUMBER 90594021 FILING DATE 03/22/2021
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY RONCORONI, LAUREN R
L.O. ASSIGNED 109

PUB INFORMATION

RUN DATE 10/27/2021
PUB DATE N/A
STATUS 680-APPROVED FOR PUBLICATION
STATUS DATE 10/26/2021
LITERAL MARK ELEMENT RADICAVA ORS

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT RADICAVA ORS
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Mitsubishi Tanabe Pharma Corporation
ADDRESS 3-2-10, Dosho-machi
Chuo-ku, Osaka-shi
Osaka, 541-8505
ENTITY 03-CORPORATION
CITIZENSHIP Japan

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical preparations for the treatment of central nervous system diseases; Pharmaceutical preparations for protection against free radicals; Pharmaceutical preparations for removing free radicals from the human bodies; Neuroprotective medicines; Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
OWNER OF US REG NOS 5277200   

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
10/26/2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 004
10/26/2021 DOCK D ASSIGNED TO EXAMINER 003
06/25/2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
03/25/2021 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Jeffrey Costellia
CORRESPONDENCE ADDRESS JEFFREY COSTELLIA
NIXON PEABODY LLP
799 9TH STREET, NW, SUITE 500
WASHINGTON, DC 20001
DOMESTIC REPRESENTATIVE Jeffrey Costellia

TRAM Snapshot of App at Pub for Oppostn [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed